TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study.

Jean van Wyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.